ginsenoside rh2 has been researched along with cyclin d1 in 5 studies
Studies (ginsenoside rh2) | Trials (ginsenoside rh2) | Recent Studies (post-2010) (ginsenoside rh2) | Studies (cyclin d1) | Trials (cyclin d1) | Recent Studies (post-2010) (cyclin d1) |
---|---|---|---|---|---|
295 | 1 | 200 | 10,885 | 70 | 5,157 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tu, ZG; Zeng, XL | 1 |
Chen, D; Li, D; Li, J; Wei, Q; Xia, J; You, Z; Zhao, L | 1 |
Chen, D; Li, D; Li, J; Liu, Z; Wei, Q; Xia, J; You, Z; Zuo, G | 1 |
Chen, DL; Chen, Y; Li, J; Li, KQ; Li, XP; Liu, ZH; Xia, J; Xiong, W | 1 |
Chen, DL; Chen, Y; Guo, P; Li, H; Li, J; Shi, Q; Shi, X; Wang, F; Xiong, W; Zuo, G | 1 |
5 other study(ies) available for ginsenoside rh2 and cyclin d1
Article | Year |
---|---|
[Effect of telomerase on ginsenoside Rh2-induced differentiation of hepatocarcinoma cell line SMMC-7721].
Topics: Carcinoma, Hepatocellular; Cell Cycle; Cell Cycle Proteins; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; DNA-Binding Proteins; Drugs, Chinese Herbal; Ginsenosides; Humans; Liver Neoplasms; Panax; Plants, Medicinal; RNA, Messenger; Telomerase | 2004 |
[Ginsenoside Rh2 inhibits proliferation and promotes apoptosis of leukemia KG1-α cells].
Topics: Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Flow Cytometry; Ginsenosides; Humans; Inhibitory Concentration 50; Leukemia; Time Factors; Tumor Suppressor Protein p53 | 2014 |
[Regulatory effect of ginsenoside Rh2 on HDAC1/2 activity and cyclin in human erythroleukemia K562 cells].
Topics: Apoptosis; Blotting, Western; Cell Cycle; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Flow Cytometry; Ginsenosides; Histone Deacetylase 1; Histone Deacetylase 2; Humans; K562 Cells; Leukemia, Erythroblastic, Acute; Time Factors | 2014 |
20(S)-ginsenoside Rh2 inhibits the proliferation and induces the apoptosis of KG-1a cells through the Wnt/β-catenin signaling pathway.
Topics: Antineoplastic Agents; Apoptosis; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; beta Catenin; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Drugs, Chinese Herbal; Flow Cytometry; G1 Phase Cell Cycle Checkpoints; Ginsenosides; Humans; Leukemia; Microscopy, Electron, Transmission; Panax; Real-Time Polymerase Chain Reaction; Transcription Factor 4; Transcription Factor RelA; Transcription Factors; Wnt Proteins; Wnt Signaling Pathway | 2016 |
Anticancer effect of 20(S)-ginsenoside Rh2 on HepG2 liver carcinoma cells: Activating GSK-3β and degrading β-catenin.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Cell Proliferation; Chromatin Immunoprecipitation; Cyclin D1; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Ginsenosides; Glycogen Synthase Kinase 3 beta; Hep G2 Cells; Humans; Immunohistochemistry; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Polymerase Chain Reaction; Xenograft Model Antitumor Assays | 2016 |